Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Bauknecht

Showing results (61-70 of 94) with videos related to

Pageof 10
Sort By:
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 10, 2001
G-CSF receptor expression in ovarian cancerE. B. Ninci, T. Brandstetter, I. Meinhold-Heerlein, et al.
Human Genetics|December 18, 1978
Appearance of hCG-receptor after conversion of newborn ovarian cells into testicular structures by H-Y antigen in vitroU Müller, M T Zenzes, T Bauknecht, et al.
Cancer|January 15, 1993
Gene structure and expression analysis of the epidermal growth factor receptor, transforming growth factor-alpha, myc, jun, and metallothionein in human ovarian carcinomas. Classification of malignant phenotypesT Bauknecht, P Angel, M Kohler, et al.
The EMBO Journal|June 1, 1991
Extinction of the HPV18 upstream regulatory region in cervical carcinoma cells after fusion with non-tumorigenic human keratinocytes under non-selective conditionsF Rösl, T Achtstätter, T Bauknecht, et al.
International Journal of Cancer|November 3, 1995
c-jun expression and growth stimulation in human ovarian carcinoma cell lines following exposure to cytokinesD M Spinner, T Brandstetter, M Kiechle-Schwarz, et al.
Nucleic Acids Research|May 11, 1991
Delineation of human papillomavirus type 18 enhancer binding proteins: the intracellular distribution of a novel octamer binding protein p92 is cell cycle regulatedH D Royer, M P Freyaldenhoven, I Napierski, et al.
Cancer Genetics and Cytogenetics|July 1, 1992
Cytogenetic analysis of an adenoid cystic carcinoma of the Bartholin's gland. A rare, semimalignant tumor of the female genitourinary tractM Kiechle-Schwarz, F Kommoss, J Schmidt, et al.
Cancer|July 1, 1995
p53 mutation and MDM2 amplification are rare even in human papillomavirus-negative cervical carcinomasH Ikenberg, K Matthay, B Schmitt, et al.
Archives of Gynecology and Obstetrics|February 24, 2001
Cross-linked type I collagen C- and N-telopeptides in women with bone metastases from breast cancerU Ulrich, K Rhiem, J Schmolling, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1994
Phase II study of pirarubicin combined with cisplatin in recurrent ovarian cancerA du Bois, H G Meerpohl, H Madjar, et al.
Pageof 10

Showing results (61-70 of 94) with videos related to

Sort By:
Pageof 10
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 10, 2001
G-CSF receptor expression in ovarian cancerE. B. Ninci, T. Brandstetter, I. Meinhold-Heerlein, et al.
Human Genetics|December 18, 1978
Appearance of hCG-receptor after conversion of newborn ovarian cells into testicular structures by H-Y antigen in vitroU Müller, M T Zenzes, T Bauknecht, et al.
Cancer|January 15, 1993
Gene structure and expression analysis of the epidermal growth factor receptor, transforming growth factor-alpha, myc, jun, and metallothionein in human ovarian carcinomas. Classification of malignant phenotypesT Bauknecht, P Angel, M Kohler, et al.
The EMBO Journal|June 1, 1991
Extinction of the HPV18 upstream regulatory region in cervical carcinoma cells after fusion with non-tumorigenic human keratinocytes under non-selective conditionsF Rösl, T Achtstätter, T Bauknecht, et al.
International Journal of Cancer|November 3, 1995
c-jun expression and growth stimulation in human ovarian carcinoma cell lines following exposure to cytokinesD M Spinner, T Brandstetter, M Kiechle-Schwarz, et al.
Nucleic Acids Research|May 11, 1991
Delineation of human papillomavirus type 18 enhancer binding proteins: the intracellular distribution of a novel octamer binding protein p92 is cell cycle regulatedH D Royer, M P Freyaldenhoven, I Napierski, et al.
Cancer Genetics and Cytogenetics|July 1, 1992
Cytogenetic analysis of an adenoid cystic carcinoma of the Bartholin's gland. A rare, semimalignant tumor of the female genitourinary tractM Kiechle-Schwarz, F Kommoss, J Schmidt, et al.
Cancer|July 1, 1995
p53 mutation and MDM2 amplification are rare even in human papillomavirus-negative cervical carcinomasH Ikenberg, K Matthay, B Schmitt, et al.
Archives of Gynecology and Obstetrics|February 24, 2001
Cross-linked type I collagen C- and N-telopeptides in women with bone metastases from breast cancerU Ulrich, K Rhiem, J Schmolling, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1994
Phase II study of pirarubicin combined with cisplatin in recurrent ovarian cancerA du Bois, H G Meerpohl, H Madjar, et al.
Pageof 10